88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


MatOrtho announces ReCerf® 5A* ODEP rating LEATHERHEAD, England , May 26, 2026 /PRNewswire/ -- MatOrtho is pleased to announce that ReCerf® has been awarded a 5A* rating by the Orthopaedic Data Evaluation Panel (ODEP), representing the highest ... 2026-05-26T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine Approval granted by South Korea's Ministry of Food and Drug Safety (MFDS) Eptinezumab is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for the preventive treatment of migraine in ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
"The Era of Cuffless is Here"… Ring-Type Blood Pressure Monitor 'CART BP pro' Becomes World's First to Be Integrated into Official Hypertension Guidelines SEOUL, South Korea , May 26, 2026 /PRNewswire/ -- Sky Labs (CEO Jack ByungHwan Lee) announced on the 26th that its ring-type cuffless blood pressure monitor, 'CART BP pro,' has been officially integrated ... 2026-05-26T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Global Times: How mutual commitment of Xizang and medical aid workers improves local healthcare BEIJING , May 26, 2026 /PRNewswire/ -- National support for Xizang's development has yielded remarkable achievements. Over the decades, numerous volunteers from across the country have come to Xizang, ... 2026-05-26T Health Care/Hospital Medical/Pharmaceuticals Publishing/Information Service
Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session HONG KONG , May 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") a nnounced that more than 40 clinical studies of its oncology portfolio will be presented ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing SUZHOU, China , May 26, 2026 /PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today ... 2026-05-26T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC) This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination with cetuximab and mFOLFOX6 demonstrated a statistically significant ... 2026-05-25T Health Care/Hospital Medical/Pharmaceuticals
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients. Data from the elacestrant ... 2026-05-25T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
THE FUTURE OF MEN'S HEALTH IS MEASURABLE: EMAGENE.LIFE AND ADAM HEALTH PARTNER TO ADVANCE PRECISION LONGEVITY AND FUNCTIONAL MEDICINE Emagene.life integrates advanced biodata intelligence, functional medicine, and Avio Health AI technology through a strategic collaboration with Adam Health to support measurable male vitality and lon ... 2026-05-25T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Most Singaporeans know about LPAs, but only 1 in 3 have made one New research by SMU highlights a gap in preparedness, socioeconomic disparities and need for stronger public support as Singapore ages ... 2026-05-25T Education Health Care/Hospital Higher Education Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals